Sulfapyridine and sulfone type drugs in dermatology.

Over approximately the past 2 decades drugs of the sulfapyridine and sulfone type have become well established in dermatologic practice as uniquely effective therapeutic agents in a puzzling variety of apparently unrelated disorders. Although these drugs were primarily introduced into medical practice as antibacterial substances, clinical experience has clearly demonstrated that their action in suppressing dermatologic disorders must rest on other than their antibacterial effect. The purpose of this communication is to survey reported dermatologic experience with these drugs and to report on observations with them at The University of Chicago Clinics. In addition, the hypothesis is proposed that the abnormal tissue reactivities characterizing the disorders responsive to these drugs share in their pathomechanisms some common denominator which is blocked by them. Elucidation of this hypothetical common denominator may well provide the key to understanding the natures of the puzzling disorders under consideration, solve the problem of mechanism of action

[1]  R. E. Burns,et al.  Subcorneal pustular dermatosis. , 1959, A.M.A. archives of dermatology.

[2]  R. Schneiderman,et al.  Dermatitis herpetiformis; specific entity or clinical complex. , 1959, The Journal of investigative dermatology.

[3]  F. A. Ellis.  Subcorneal pustular dermatosis. , 1958, A.M.A. archives of dermatology.

[4]  J. Jefferson.  Sulphamethoxypyridazine in Dermatitis Herpetiformis , 1958, British medical journal.

[5]  Winkelmann Rk,et al.  Dermatitis herpetiformis treated with sulfamethoxypyridazine; preliminary report. , 1958 .

[6]  S. Ayres.  Pyoderma gangrenosum with an unusual syndrome of ulcers, vesicles, and arthritis. , 1958, A.M.A. archives of dermatology.

[7]  F. Hellier.  GENERALIZED PUSTULAR BACTERTD. ITS RELATIONSHIP TO THE PUSTULAR DERMATOSIS OF SNEDDON AND WILKINSON. , 1956, The British journal of dermatology.

[8]  R. K. Poddar,et al.  Preferential Uptake of Sulphone by Affected Skin Tissue of Leprosy Patients as detected by a Tracer Method , 1956, Nature.

[9]  T. Cornbleet.  Sulfone drugs in Duhring's disease; further experience. , 1956, The Journal of investigative dermatology.

[10]  T. Granroth.  Dermatitis herpetiformis treated with D.A.D.P.S. (diaminodiphenylsulfone). , 1956, Acta dermato-venereologica.

[11]  C. M. Buncke,et al.  Dermatitis herpetiformis (Duhring) successfully treated with promacetin. , 1955, A.M.A. archives of dermatology.

[12]  E. Schoch,et al.  The effect of salicylazosulfapyridine (azulfidine) on pustular acne vulgaris and certain other dermatoses. , 1955, The Journal of investigative dermatology.

[13]  J. O. Alexander.  Dapsone in the treatment of dermatitis herpetiformis. , 1955, Lancet.

[14]  J. K. Morgan,et al.  Dapsone in dermatitis herpetiformis. , 1955, Lancet.

[15]  Vickers Hr.  Advances in the treatment of skin diseases. , 1954 .

[16]  J. Doull,et al.  Sulfone therapy of leprosy. , 1954, The Medical clinics of North America.

[17]  E. Kruizinga,et al.  Treatment of dermatitis herpetiformis with diamino-diphenyl-sulphone (D.D.S.). , 1953, Dermatologica.

[18]  J. Lowe.  Studies in sulphone therapy. , 1952, Leprosy review.

[19]  T. Cornbleet.  SULFOXONE (DIASONE®) SODIUM FOR DERMATITIS HERPETIFORMIS , 1951 .

[20]  J. A. Bargen.  The medical treatment of ulcerative colitis. , 1951, Postgraduate medicine.

[21]  G. Andrews,et al.  Treatment of acne vulgaris. , 1951, Journal of the American Medical Association.

[22]  A. Curtis,et al.  Para-aminobenzoic acid in dermatitis herpetiformis. , 1951, A.M.A. archives of dermatology and syphilology.

[23]  S. H. Ross.  Studies of the absorption, excretion, and distribution in the body of the sulfones used in the treatment of leprosy. , 1950 .

[24]  Dharmendra.,et al.  Diamlno-Diphenyl-Sulphone (DDS) in the Treatment of Leprosy : Pharmacological Aspects. , 1950 .

[25]  Costello Mj.  Chronic exudative lichenoid and discoid dermatosis treated successfully with intravenous injection of typhoid and paratyphoid vaccine, sunlight and salt water bathing. , 1949 .

[26]  K. Ramanujam,et al.  Two-and-a-Half Years' Experimental Work on the Sulphone Group of Drugs. , 1949 .

[27]  M. Costello.  Sulfapyridine in the treatment of dermatitis herpetiformis. , 1947, Archives of dermatology and syphilology.

[28]  H. Arnold.  NODULAR NONSUPPURATIVE PANNICULITIS (WEBER-CHRISTIAN DISEASE): PRELIMINARY REPORT OF A CASE CONTROLLED BY SULFAPYRIDINE , 1945 .

[29]  A. F. Hall.  IMPETIGO HERPETIFORMIS IN THE MALE: REPORT OF ONE CASE WITH RESPONSE TO SULFAPYRIDINE , 1944 .

[30]  W. F. Lever.  ACRODERMATITIS CONTINUA (HALLOPEAU): EFFECT OF TREATMENT WITH SULFAPYRIDINE , 1944 .

[31]  W. Feldman,et al.  The Effect of Promin (Sodium Salt of P,P'-Diamino-Diphenyl-Sulfone-N,N'-Dextrose Sulfonate) on Experimental Tuberculosis: A Preliminary Report. , 1940 .

[32]  G. Evans,et al.  TREATMENT OF PNEUMONIA WITH 2-(p-AMINOBENZENESULPHONAMIDO) PYRIDINE , 1938 .

[33]  W. Oliver,et al.  CASE OF MASSIVE PNEUMONIA, TYPE III, WITH MASSIVE COLLAPSE, TREATED WITH 2-(p-AMINOBENZENESULPHONAMIDO) PYRIDINE , 1938 .

[34]  G. E. Foster,et al.  THE TREATMENT OF STREPTOCOCCAL INFECTIONS IN MICE WITH 4:4'DIAMINODIPHENYLSULPHONE , 1937 .